PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 10 days 18 hours 42 minutes
Journal Club on Pivotal Data in Multiple Sclerosis: How Will They Impact Clinical Practice?
Go online to www.peervoice.com/h/pvj15 to view the entire programme with slides.
Expert Perspectives on Immunogenicity in Psoriasis: Understanding Its Impact on Patient Outcomes
Go online to www.peervoice.com/h/pve43 to view the entire programme with slides.
Improving Outcomes in Cystic Fibrosis: Novel Strategies and Adherence
Improving Outcomes in Cystic Fibrosis: Novel Strategies and Adherence
Going Beyond Conventional Management in IBD: What Do Recent Advances Mean for Practice
Go online to www.peervoice.com/h/pvs57 to view the entire programme with slides.
Stepping Up Care for Acromegaly With Early Diagnosis and Emerging Therapeutic Options
Go online to www.peervoice.com/h/pvr116 to view the entire programme with slides.
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Spotlight on Multifocal Motor Neuropathy: Strategies to Improve Diagnosis and Treatment
Spotlight on Multifocal Motor Neuropathy: Strategies to Improve Diagnosis and Treatment
PARPs in Practice in mCRPC: A Look at the Latest Data
PARPs in Practice in mCRPC: A Look at the Latest Data
Current and Emerging Radiopharmaceuticals for Prostate Cancer: Is There a Role for Both?
Current and Emerging Radiopharmaceuticals for Prostate Cancer: Is There a Role for Both?
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?